Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006;33(1):57-9.

Guillain-Barré syndrome as a cause of reversible cardiomyopathy

Affiliations
Case Reports

Guillain-Barré syndrome as a cause of reversible cardiomyopathy

Jason S Finkelstein et al. Tex Heart Inst J. 2006.

Abstract

Although autonomic dysfunction is a common manifestation of Guillain-Barré syndrome, cardiovascular involvement in this setting has rarely been reported in the literature. We describe a case of reversible left ventricular systolic dysfunction in a 60-year-old man with Guillain-Barré syndrome. Our patient had no history or signs of cardiac dysfunction on initial presentation. During the clinical manifestation of his autonomic dysfunction, he developed electrocardiographic changes accompanied by mildly elevated cardiac enzymes and severe left ventricular systolic dysfunction and segmental wall motion abnormality, which coincided with elevated urinary catecholamine and vanilmandelic acid levels. These abnormalities, and his symptoms, resolved rapidly once the acute episode was over. We believe the reversible left ventricular dysfunction was due to the toxic effect of increased catecholamines and to the transiently damaged sympathetic nerve endings in the myocardium, presumably a consequence of Guillain-Barré syndrome. We recommend that echocardiography be performed in patients with clinical signs of autonomic dysfunction, especially if they are associated with abnormal electrocardiographic findings, cardiac enzyme elevation, or hemodynamic instability, so that appropriate medical therapy can be instituted in a timely manner.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Iga K, Himura Y, Izumi C, Miyamoto T, Kijima K, Gen H, Konishi T. Reversible left ventricular dysfunction associated with Guillain-Barre syndrome—an expression of catecholamine cardiotoxicity? Jpn Circ J 1995;59:236–40. - PubMed
    1. Hiraga A, Nagumo K, Suzuki K, Sakakibara Y, Kojima S. A patient with Guillain-Barre syndrome and recurrent episodes of ST elevation and left ventricular hypokinesis in the anterior wall [in Japanese]. No To Shinkei 2003;55:517–20. - PubMed
    1. Bernstein R, Mayer SA, Magnano A. Neurogenic stunned myocardium in Guillain-Barre syndrome. Neurology 2000; 54:759–62. - PubMed
    1. Mayer SA, Swarup R. Neurogenic cardiac injury after subarachnoid hemorrhage. Curr Opin Anaesthesiol 1996;9: 356–61.
    1. Samuels MA. “Voodoo” death revisited: the modern lessons of neurocardiology. Neurologist 1997;3:293–304. - PubMed

Publication types